Combination of Steroid and Humanized CD25 Monoclonal Antibody as First-line Therapy for aGVHD

Clinical trial NCT06473909 · UNKNOWN

Trial details

NCT number: NCT06473909
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Graft Versus Host Disease

Start date: 2024-07-01
Primary completion: 2025-12-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.